HIV-GB virus C co-infection: An overview

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 1, 2009, Pages 12-19

  Baggio Zappia, Giovana Lotici ^a   Hernandes Granato, Celso Francisco ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Fleury   (Brazil)

Author keywords

Co infection; GB virus C; Hepatitis viruses; HIV; Viral interference

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; VIRUS RNA;

CLINICAL FEATURE; DISEASE COURSE; FLUORESCENCE IN SITU HYBRIDIZATION; GENETIC VARIABILITY; HEPATITIS G; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROPHILICITY; IMMUNE SYSTEM; MEDICAL RESEARCH; MORTALITY; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; REVIEW; VIRUS GENOME; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS TRANSMISSION;

FLAVIVIRIDAE INFECTIONS; GB VIRUS C; GENOTYPE; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HUMANS; VIRAL INTERFERENCE;

GB VIRUS C;

EID: 58149269178     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.001     Document Type: Review

References (107)

1. Linnen J, Wages J Jr, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996;271:505-8.
2. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, et al. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995;1:564-9.
3. Simons JN, Pilot-Matias TJ, Leary TP, Dawson GJ, Desai SM, Schlauder GG, et al. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA 1995;92:3401-5.
4. Lim MY, Fry K, Yun A, Chong S, Linnen J, Fung K, et al. Sequence variation and phylogenetic analysis of envelope glycoprotein of hepatitis G virus. J Gen Virol 1997;78:2771-7.
5. Leary TP, Muerhoff AS, Simons JN, Pilot-Matias TJ, Erker JC, Chalmers ML, et al. Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human non-A-E hepatitis. J Med Virol 1996;48:60-7.
6. Radkowski M, Przyjalkowski W, Lipowski D, Wang LF, Laskus T. Lack of GB virus C/hepatitis G virus sequences in cerebrospinal fluid in patients with central nervous system infections. Scand J Infect Dis 1998;30:539.
7. Kanda Y, Chiba S, Kami M, Asai T, Tanaka Y, Saito T, et al. Quantitation of hepatitis G virus RNA in allogeneic bone marrow transplant recipients. Stem Cell Transplantation Team. Br J Haematol 1998;100:798-800.
8. Supapol WB, Remis RS, Raboud J, Millson M, Tappero J, Kaul R, et al. Reduced mother-to-child transmission of HIV associated with infant but not maternal GB virus C infection. J Infect Dis 2008;197:1369-77.
9. Lara C, Halasz R, Sonnerborg A, Sallberg M. Detection of hepatitis G virus RNA in persons with and without known risk factors for blood-borne viral infections in Sweden and Honduras. J Clin Microbiol 1998;36:255-7.
10. Feucht HH, Zollner B, Polywka S, Knodler B, Schroter M, Nolte H, et al. Prevalence of hepatitis G viremia among healthy subjects, individuals with liver disease, and persons at risk for parenteral transmission. J Clin Microbiol 1997;35:767-8.
11. Thomas DL, Nakatsuji Y, Shih JW, Alter HJ, Nelson KE, Astemborski JA, et al. Persistence and clinical significance of hepatitis G virus infections in injecting drug users. J Infect Dis 1997;176:586-92.
12. Alter HJ. G-pers creepers, where'd you get those papers? A reassessment of the literature on the hepatitis G virus. Transfusion 1997;37:569-72.
13. Alter HJ, Nakatsuji Y, Melpolder J, Wages J, Wesley R, Shih JW, et al. The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997;336:747-54.
14. Masuko K, Mitsui T, Iwano K, Yamazaki C, Okuda K, Meguro T, et al. Infection with hepatitis GB virus C in patients on maintenance hemodialysis. N Engl J Med 1996;334:1485-90.
15. Dawson GJ, Schlauder GG, Pilot-Matias TJ, Thiele D, Leary TP, Murphy P, et al. Prevalence studies of GB virus-C infection using reverse transcriptase-polymerase chain reaction. J Med Virol 1996;50:97-103.
16. Stark K, Bienzle U, Hess G, Engel AM, Hegenscheid B, Schluter V. Detection of the hepatitis G virus genome among injecting drug users, homosexual and bisexual men, and blood donors. J Infect Dis 1996;174:1320-3.
17. Thomas DL, Vlahov D, Alter HJ, Hunt JC, Marshall R, Astemborski J, et al. Association of antibody to GB virus C (hepatitis G virus) with viral clearance and protection from reinfection. J Infect Dis 1998;177:539-42.
18. Kitamoto M, Moriya T, Sasaki F, Katayama K, Yoshizawa H, Asahara T, et al. wDetection of GBV-C RNA among non B non C hepatocellular carcinoma patientsx. Nippon Rinsho 1997;55:583-6. In Japanese.
19. Katayama Y, Apichartpiyakul C, Handajani R, Ishido S, Hotta H. GB virus C/hepatitis G virus (GBV-C/HGV) infection in Chiang Mai, Thailand, and identification of variants on the basis of 5′-untranslated region sequences. Arch Virol 1997;142:2433-45.
20. Ruiz V, Espinola L, Mathet VL, Perandones CE, Oubina JR. Design, development and evaluation of a competitive RT-PCR for quantitation of GBV-C RNA. J Virol Methods 2006;136:58-64.
21. Seipp S, Scheidel M, Hofmann WJ, Tox U, Theilmann L, Goeser T, et al. Hepatotropism of GB virus C (GBV-C): GBV-C replication in human hepatocytes and cells of human hepatoma cell lines. J Hepatol 1999;30:570-9.
22. Kato T, Mizokami M, Nakano T, Orito E, Ohba K, Kondo Y, et al. Heterogeneity in E2 region of GBV-C/hepatitis G virus and hepatitis C virus. J Med Virol 1998;55:109-17.
23. Tillmann HL, Heringlake S, Trautwein C, Meissner D, Nashan B, Schlitt HJ, et al. Antibodies against the GB virus C envelope 2 protein before liver transplantation protect against GB virus C de novo infection. Hepatology 1998;28:379-84.
24. Tacke M, Schmolke S, Schlueter V, Sauleda S, Esteban JI, Tanaka E, et al. Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery from infection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors. Hepatology 1997;26:1626-33.
25. Williams CF, Klinzman D, Yamashita TE, Xiang J, Polgreen PM, Rinaldo C, et al. Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med 2004;350:981-90.
26. Berzsenyi MD, Roberts SK. What is the role of GB virus C infection in hepatitis C virus/HIV coinfection? J Infect Dis 2006;194:407-9.
27. Muerhoff AS, Leary TP, Simons JN, Pilot-Matias TJ, Dawson GJ, Erker JC, et al. Genomic organization of GB viruses A and B: two new members of the Flaviviridae associated with GB agent hepatitis. J Virol 1995;69:5621-30.
28. Schlauder GG, Pilot-Matias TJ, Gabriel GS, Simons JN, Muerhoff AS, Dawson GJ, et al. Origin of GB-hepatitis viruses. Lancet 1995;346:447-8.
29. Simons JN, Desai SM, Schultz DE, Lemon SM, Mushahwar IK. Translation initiation in GB viruses A and C: evidence for internal ribosome entry and implications for genome organization. J Virol 1996;70:6126-35.
30. Polgreen PM, Xiang J, Chang Q, Stapleton JT. GB virus type C/hepatitis G virus: a non-pathogenic flavivirus associated with prolonged survival in HIV-infected individuals. Microbes Infect 2003;5:1255-61.
31. Muerhoff AS, Simons JN, Leary TP, Erker JC, Chalmers ML, Pilot-Matias TJ, et al. Sequence heterogeneity within the 5′-terminal region of the hepatitis GB virus C genome and evidence for genotypes. J Hepatol 1996;25:379-84.
32. Okamoto H, Nakao H, Inoue T, Fukuda M, Kishimoto J, Iizuka H, et al. The entire nucleotide sequences of two GB virus C/hepatitis G virus isolates of distinct genotypes from Japan. J Gen Virol 1997;78:737-45.
33. Xiang J, Daniels KJ, Soll DR, Schmidt WN, Labrecque DR, Stapleton JT. Visualization and characterization of GB virus-C particles: evidence for a nucleocapsid. J Viral Hepat 1999;6(Suppl 1):16-22.
34. Xiang J, Klinzman D, McLinden J, Schmidt WN, La-Brecque DR, Gish R, et al. Characterization of hepatitis G virus (GB-C virus) particles: evidence for a nucleocapsid and expression of sequences upstream of the E1 protein. J Virol 1998;72:2738-44.
35. Fogeda M, Navas S, Martin J, Casqueiro M, Rodriguez E, Arocena C, et al. In vitro infection of human peripheral blood mononuclear cells by GB virus C/Hepatitis G virus. J Virol 1999;73:4052-61.
36. Pinho JR, Capacci ML, da Silva LC, Carrilho FJ, Santos CA, Pugliese V, et al. Hepatitis G virus/GB virus C in Brazil. Preliminary report. Rev Inst Med Trop Sao Paulo 1996;38:243-6.
37. Wu RR, Mizokami M, Cao K, Nakano T, Ge XM, Wang SS, et al. GB virus C/hepatitis G virus infection in southern China. J Infect Dis 1997;175:168-71.
38. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995;346:1131-2.
39. Heringlake S, Osterkamp S, Trautwein C, Tillmann HL, Boker K, Muerhoff S, et al. Association between fulminant hepatic failure and a strain of GBV virus C. Lancet 1996;348:1626-9.
40. Heringlake S, Tillmann HL, Cordes-Temme P, Trautwein C, Hunsmann G, Manns MP. GBV-C/HGV is not the major cause of autoimmune hepatitis. J Hepatol 1996;25:980-4.
41. Kao JH, Chen PJ, Chen DS. GBV-C in the aetiology of fulminant hepatitis. Lancet 1996;347:120-1.
42. Tucker TJ, Smuts HE, Eedes C, Knobel GD, Eickhaus P, Robson SC, et al. Evidence that the GBV-C/hepatitis G virus is primarily a lymphotropic virus. J Med Virol 2000;61:52-8.
43. Alter MJ, Gallagher M, Morris TT, Moyer LA, Meeks EL, Krawczynski K, et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. Sentinel Counties Viral Hepatitis Study Team. N Engl J Med 1997;336:741-6.
44. Kobayashi M, Tanaka E, Nakayama J, Furuwatari C, Katsuyama T, Kawasaki S, et al. Detection of GB virus-C/hepatitis G virus genome in peripheral blood mononuclear cells and liver tissue. J Med Virol 1999;57:114-21.
45. Xiang J, Wunschmann S, Schmidt W, Shao J, Stapleton JT. Full-length GB virus C (hepatitis G virus) RNA transcripts are infectious in primary CD4-positive T cells. J Virol 2000;74:9125-33.
46. Barbosa AJ, Baggio GL, Dobo C, Lanzoni VP, Lanzara G, Granato CF. Análise laboratorial e histologia hepática na infecçã o pelo GBV-C em pacientes HIV soropositivos coinfectados pelo vírus da Hepatite C. Presented at: 42° Congresso Brasileiro de Patologia Clínica Medicina Laboratorial, Salvador, BA, 2-5 Julho 2008. Abstract in Portuguese.
47. Laras A, Zacharakis G, Hadziyannis SJ. Absence of the negative strand of GBV-C/HGV RNA from the liver. J Hepatol 1999;30:383-8.
48. Fabris P, Biasin MR, Infantolino D, Romano L, Benedetti P, Tositti G, et al. HGV/GBV-C in liver tissue and in sera from patients with chronic hepatitis C. Infection 1998;26:283-7.
49. Pessoa MG, Terrault NA, Detmer J, Kolberg J, Collins M, Hassoba HM, et al. Quantitation of hepatitis G and C viruses in the liver: evidence that hepatitis G virus is not hepatotropic. Hepatology 1998;27:877-80.
50. Sathar MA, York DF, Gouws E, Coutsoudis A, Coovadia HM. GB virus type C coinfection in HIV-infected African mothers and their infants, KwaZulu Natal, South Africa. Clin Infect Dis 2004;38:405-9.
51. Smith DB, Cuceanu N, Davidson F, Jarvis LM, Mokili JL, Hamid S, et al. Discrimination of hepatitis G virus/GBVC geographical variants by analysis of the 59 non-coding region. J Gen Virol 1997;78:1533-42.
52. Muerhoff AS, Smith DB, Leary TP, Erker JC, Desai SM, Mushahwar IK. Identification of GB virus C variants by phylogenetic analysis of 5′-untranslated and coding region sequences. J Virol 1997;71:6501-8.
53. Naito H, Abe K. Genotyping system of GBV-C/HGV type 1 to type 4 by the polymerase chain reaction using type-specific primers and geographical distribution of viral genotypes. J Virol Methods 2001;91:3-9.
54. Tanaka Y, Mizokami M, Orito E, Ohba K, Kato T, Kondo Y, et al. African origin of GB virus C/hepatitis G virus. FEBS Lett 1998;423:143-8.
55. Sathar MA, Soni PN, Pegoraro R, Simmonds P, Smith DB, Dhillon AP, et al. A new variant of GB virus C/hepatitis G virus (GBV-C/HGV) from South Africa. Virus Res 1999;64:151-60.
56. Toyoda H, Fukuda Y, Hayakawa T, Takamatsu J, Saito H. Effect of GB virus C/hepatitis G virus coinfection on the course of HIV infection in hemophilia patients in Japan. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:209-13.
57. Heringlake S, Ockenga J, Tillmann HL, Trautwein C, Meissner D, Stoll M, et al. GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients? J Infect Dis 1998;177:1723-6.
58. Tillmann HL, Manns MP. GB virus-C infection in patients infected with the human immunodeficiency virus. Antiviral Res 2001;52:83-90.
59. Tillmann HL, Heiken H, Knapik-Botor A, Heringlake S, Ockenga J, Wilber JC, et al. Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 2001;345:715-24.
60. Xiang J, Wunschmann S, Diekema DJ, Klinzman D, Patrick KD, George SL, et al. Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med 2001;345:707-14.
61. Aronoff DM. Using live pathogens to treat infectious diseases: a historical perspective on the relationship between GB virus C and HIV. Antivir Ther 2002;7:73-80.
62. Tillmann HL, Manns MP, Claes C, Heiken H, Schmidt RE, Stoll M. GB virus C infection and quality of life in HIV-positive patients. AIDS Care 2004;16:736-43.
63. Yeo AE, Matsumoto A, Hisada M, Shih JW, Alter HJ, Goedert JJ. Effect of hepatitis G virus infection on progression of HIV infection in patients with hemophilia. Multicenter Hemophilia Cohort Study. Ann Intern Med 2000;132:959-63.
64. Rodriguez B, Woolley I, Lederman MM, Zdunek D, Hess G, Valdez H. Effect of GB virus C coinfection on response to antiretroviral treatment in human immunodeficiency virus-infected patients. J Infect Dis 2003;187:504-7.
65. Antonucci G, Girardi E, Cozzi-Lepri A, Capobianchi MR, Morsica G, Pizzaferri P, et al. Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals. Antivir Ther 2005;10:109-17.
66. Mosam A, Sathar MA, Dawood H, Cassol E, Esterhuizen TM, Coovadia HM. Effect of GB virus C co-infection on response to generic HAART in African patients with HIV-1 clade C infection. Aids 2007;21:1377-9.
67. Zhu T, Ding XP, Wan YM, Liu LX, Peng H, Huang XG, et al. wEffect of GBV-C/HIV coinfection on HIV/AIDS disease progression and HIV replicationx. Bing Du Xue Bao 2008;24:17-21. In Chinese.
68. Birk M, Lindback S, Lidman C. No influence of GB virus C replication on the prognosis in a cohort of HIV-1-infected patients. AIDS 2002;16:2482-5.
69. Björkman P, Flamholc L, Naucler A, Molnegren V, Wallmark E, Widell A. GB virus C during the natural course of HIV-1 infection: viremia at diagnosis does not predict mortality. AIDS 2004;18:877-86.
70. Björkman P, Flamholc L, Molnegren V, Marshall A, Guner N, Widell A. Enhanced and resumed GB virus C replication in HIV-1-infected individuals receiving HAART. AIDS 2007;21:1641-3.
71. th IFCC WorldLab 2008, Fortaleza, Brazil, 28 Sep-2 Oct, 2008.
72. Petrik J, Guella L, Wight DG, Pearson GM, Hinton J, Parker H, et al. Hepatic histology in hepatitis C virus carriers coinfected with hepatitis G virus. Gut 1998;42:103-6.
73. Saitoh H, Moriyama M, Matsumura H, Goto I, Tanaka N, Aarakawa Y. The clinical significance of GBV-C/HGV exposure in C-viral chronic liver disease and blood donors. Hepatol Res 2002;22:288-96.
74. Barusruk S, Urwijitaroon Y. High prevalence of HGV coinfection with HBV or HCV among northeastern Thai blood donors. Southeast Asian J Trop Med Public Health 2006;37:289-93.
75. Stapleton J. A new variable influencing HCV-related liver disease in HIV-HCV coinfected individuals? Gastroenterology 2007;133:2042-5.
76. Sarrazin C, Herrmann G, Roth WK, Lee JH, Marx S, Zeuzem S. Prevalence and clinical and histological manifestation of hepatitis G/GBV-C infections in patients with elevated aminotransferases of unknown etiology. J Hepatol 1997;27:276-83.
77. Berg T, Dirla U, Naumann U, Heuft HG, Kuther S, Lobeck H, et al. Responsiveness to interferon alpha treatment in patients with chronic hepatitis C coinfected with hepatitis G virus. J Hepatol 1996;25:763-8.
78. Berg T, Naumann U, Fukumoto T, Bechstein WO, Neuhaus P, Lobeck H, et al. GB virus C infection in patients with chronic hepatitis B and C before and after liver transplantation. Transplantation 1996;62:711-4.
79. Grassi M, Mammarella A, Sagliaschi G, Granati L, Musca A, Traditi F, et al. Persistent hepatitis G virus (HGV) infection in chronic hemodialysis patients and non-B, non-C chronic hepatitis. Clin Chem Lab Med 2001;39:956-60.
80. Chu C, Hwang S, Luo J, Wang Y, Lu R, Lai C, et al. Clinical, virological, immunological, and pathological significance of GB virus C/hepatitis G infection in patients with chronic hepatitis C. Hepatol Res 2001;19:225-36.
81. Berzsenyi MD, Bowden DS, Kelly HA, Watson KM, Mijch AM, Hammond RA, et al. Reduction in hepatitis C-related liver disease associated with GB virus C in human immunodeficiency virus coinfection. Gastroenterology 2007;133:1821-30.
82. Strauss E, da Costa Gayotto LC, Fay F, Fay O, Fernandes HS, Fisher Chamone D de A. Liver histology in co-infection of hepatitis C virus (HCV) and hepatitis G virus (HGV). Rev Inst Med Trop Sao Paulo 2002;44:67-70.
83. Shang Q, Yu J, Zhuo H, Xu C, Wang N, Zhang G. [Relationship between amount of HBV DNA in serum/liver tissue and hepatitis G virus (HGV) infection in patients with chronic hepatitis B]. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 2002;16:326-8. In Chinese.
84. Poli G, Fauci AS. Cytokine modulation of HIV expression. Semin Immunol 1993;5:165-73.
85. Castedo M, Ferri KF, Blanco J, Roumier T, Larochette N, Barretina J, et al. Human immunodeficiency virus 1 envelope glycoprotein complex-induced apoptosis involves mammalian target of rapamycin/FKBP12-rapamycin-associated protein-mediated p53 phosphorylation. J Exp Med 2001;194:1097-110.
86. Xiang J, George SL, Wunschmann S, Chang Q, Klinzman D, Stapleton JT. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1. Lancet 2004;363:2040-6.
87. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, et al. Binding of hepatitis C virus to CD81. Science 1998;282:938-41.
88. Nattermann J, Nischalke HD, Kupfer B, Rockstroh J, Hess L, Sauerbruch T, et al. Regulation of CC chemokine receptor 5 in hepatitis G virus infection. AIDS 2003;17:1457-62.
89. Xiang J, McLinden J, Chang Q, Klinzman D, Kaufman T, Montefiori D. Monoclonal antibodies directed against the GB virus C major envelope glycoprotein neutralize HIV infectivity differentially in PBMC than in TZB-bl cells. In: 13th Conference on Retroviruses and Opportunistic Infections (CROI), Denver, CO, 5-8 February, 2006.
90. Jung S, Eichenmuller M, Donhauser N, Neipel F, Engel AM, Hess G, et al. HIV entry inhibition by the envelope 2 glycoprotein of GB virus C. AIDS 2007;21:645-7.
91. Xiang J, McLinden JH, Chang Q, Kaufman TM, Stapleton JT. An 85-aa segment of the GB virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T cells. Proc Natl Acad Sci USA 2006;103:15570-5.
92. Xiang J, McLinden JH, Chang Q, Jordan EL, Stapleton JT. Characterization of a peptide domain within the GB virus C NS5A phosphoprotein that inhibits HIV replication. PLoS ONE 2008;3:e2580.
93. Nunnari G, Nigro L, Palermo F, Attanasio M, Berger A, Doerr HW, et al. Slower progression of HIV-1 infection in persons with GB virus C co-infection correlates with an intact T-helper 1 cytokine profile. Ann Intern Med 2003;139:26-30.
94. Spellberg B, Edwards JE Jr. Type 1/type 2 immunity in infectious diseases. Clin Infect Dis 2001;32:76-102.
95. Breen EC. Pro- and anti-inflammatory cytokines in human immunodeficiency virus infection and acquired immunodeficiency syndrome. Pharmacol Ther 2002;95:295-304.
96. George S, Varmaz D, Stapleton J. GB virus C inhibits apoptosis in PBMCs. In: 11th International Conference on Hepatitis C and Related Flaviviruses, Heidelberg, Germany, 3-7 October 2004.
97. Hengartner MO. The biochemistry of apoptosis. Nature 2000;407:770-6.
98. Sousa AE, Carneiro J, Meier-Schellersheim M, Grossman Z, Victorino RM. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J Immunol 2002;169:3400-6.
99. Kabelitz D, Wesch D. Role of gamma delta T-lymphocytes in HIV infection. Eur J Med Res 2001;6:169-74.
100. Capobianchi MR, Lalle E, Martini F, Poccia F, D'Offizi G, Antonucci G, et al. Influence of GBV-C infection on the endogenous activation of the IFN system in HIV-1 coinfected patients. Cell Mol Biol (Noisy-le-grand) 2006;52:3-8.
101. Lalle E, Sacchi A, Abbate I, Vitale A, Martini F, D'Offizi G, et al. Activation of interferon response genes and of plasmacytoid dendritic cells in HIV-1 positive subjects with GB virus C co-infection. Int J Immunopathol Pharmacol 2008;21:161-71.
102. Sacchi A, Lalle E, Martini F, Abbate I, Castilletti C, D'Offizi G, et al. GB-virus type C effect on HIV infection, interferon system, and dendritic cells. Arch Med Res 2008;39:362-3.
103. Haji Molla Hoseini M, Pourfathollah AA, Mohraz M, Soheili Z, Amini S, Aghaiepour M, et al. Evaluation of circulating natural type 1 interferon-producing cells in HIV/GBV-C and HIV/HCV coinfected patients: a preliminary study. Arch Med Res 2007;38:868-75.
104. Bhatnagar N, Moenkemeyer M, Hong H, Schimidt R, Heiken H. Plasmacytoid dendritic cells expressing CD40+ and CD83+ are increased in HIV-1 patients with GBV-C coinfection. In: 14th Conference on Retroviruses and Opportunistic Infections (CROI), Los Angeles, CA, 25-28 February 2007.
105. Siegal F. Interferon-producing plasmacytoid dendritic cells and the pathogenesis of AIDS. Res Initiat Treat Action 2003;8:10-3.
106. Arrode G, Finke JS, Zebroski H, Siegal FP, Steinman RM. CDZ8+ T cells from most HIV-1-infected patients, even when challenged with mature dendritic cells, lack functional recall memory to HIV gag but not other viruses. Eur J Immunol 2005;35:159-70.
107. Martini F, Sacchi A, Lalle E, Castilletti C, D'Offizi G, Abbate I, et al. GB virus type C-driven protection in HIV/HCV coinfection: possible role of interferon gamma and dendritic cell activation. Gastroenterology 2008;134:1631-3. Author reply 1633.